ProCE Banner Activity

CE

Barriers and Solutions to Expanding PrEP Uptake: A Nursing Perspective

Multimedia

Listen to expert faculty as they discuss inequities in PrEP uptake in key populations, structural barriers to PrEP adoption, and solutions for expanding PrEP use.

Pharmacists: 1.00 contact hour (0.1 CEUs)

Released: June 14, 2022

Expiration: June 13, 2023

No longer available for credit.

Share

Faculty

Joseph J. Eron Jr.

Joseph J. Eron Jr., MD

Professor of Medicine, School of Medicine
Herman and Louise Smith Distinguished Professor
Chief, Division of Infectious Diseases
Director, Clinical Core, UNC Center for AIDS Research
Adjunct Professor of Epidemiology
Gillings School of Global Public Health
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Jeffrey Kwong

Jeffrey Kwong, DNP, MPH, AGPCNP-BC, FAANP, FAAN

Professor, Division of Advanced Nursing Practice
Rutgers, The State University of New Jersey
Newark, New Jersey
Nurse Practitioner
Gotham Medical Group
New York, New York

Milena Murray

Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP

Associate Professor
Department of Pharmacy Practice
Midwestern University College of Pharmacy, Downers Grove Campus
Downers Grove, Illinois
System-Level HIV/ID Clinical Pharmacist
Ambulatory Pharmacy
Northwestern Medicine
Wheaton, Illinois

Christopher Fox

Christopher Fox, MSN, RN, ANP-BC, AAHIVS

Assistant Professor of Medicine
Division of General Internal Medicine & Geriatrics
Nurse Practitioner
Internal Medicine Clinic / HIV Clinic
Oregon Health & Science University
Portland, Oregon 

Provided by

Jointly provided by the Association of Nurses in AIDS Care and Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from

ViiV Healthcare

Target Audience

This program is intended for registered nurses, pharmacists, and other healthcare professionals who provide care for patients with HIV infection.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Apply a thorough understanding of available clinical data, practice guidelines, and patient preferences to ensure that long-acting ART is considered as a treatment strategy for patients for whom it may be appropriate
  • Integrate strategies to administer long-acting ART, support patient adherence to dosing visits, and monitor its efficacy and safety in clinical settings
  • Appraise the role of long-acting PrEP in HIV prevention strategies based on considerations including efficacy, safety, and patient preferences

Program Director Disclosure

Program Director

Joseph J. Eron Jr., MD

Professor of Medicine, School of Medicine
Herman and Louise Smith Distinguished Professor
Chief, Division of Infectious Diseases
Director, Clinical Core, UNC Center for AIDS Research
Adjunct Professor of Epidemiology
Gillings School of Global Public Health
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Joseph J. Eron, Jr., MD: consultant/advisor/speaker: Gilead Sciences, GlaxoSmithKline, Janssen, Merck, ViiV; researcher: Gilead Sciences, ViiV.

Jeffrey Kwong, DNP, MPH, AGPCNP-BC, FAANP, FAAN

Professor, Division of Advanced Nursing Practice
Rutgers, The State University of New Jersey
Newark, New Jersey
Nurse Practitioner
Gotham Medical Group
New York, New York

Jeffrey Kwong, DNP, MPH, FAANP, FAAN, has no relevant conflicts of interest to report.

Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP

Associate Professor
Department of Pharmacy Practice
Midwestern University College of Pharmacy, Downers Grove Campus
Downers Grove, Illinois
System-Level HIV/ID Clinical Pharmacist
Ambulatory Pharmacy
Northwestern Medicine
Wheaton, Illinois

Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP, has disclosed that she has received consultant/advisor/speaker fees from Gilead Sciences, Janssen, Merck, Theratechnologies, and ViiV Healthcare.

Faculty Disclosure

Primary Author

Christopher Fox, MSN, RN, ANP-BC, AAHIVS

Assistant Professor of Medicine
Division of General Internal Medicine & Geriatrics
Nurse Practitioner
Internal Medicine Clinic / HIV Clinic
Oregon Health & Science University
Portland, Oregon 

Christopher Fox, MSN, RN, ANP-BC, AAHIVS, has no relevant conflicts of interest to report.

Staff Disclosure

Staff

Jessica L. Adams, PharmD, AAHIVE

Scientific Director, Infectious Diseases
Clinical Care Options
New York, United States

Jessica Adams, PharmD, has no relevant conflicts of interest to report.

Petra Cravens, PhD

Editorial Contributor

Petra Cravens, PhD, has no relevant conflicts of interest to report.

Zachary Schwartz, MSc, ELS

Scientific Director

Zachary Schwartz, MSc, ELS, has no relevant conflicts of interest to report.

Instructions for Credit

Credit Designation

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-22-154-H02-P.

Type of Activity: Application

Upon successfully completing the post-test with a score of 50% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Additional Information

Participation in this self-study activity should be completed in approximately 1 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from June 14, 2022, through June 13, 2023:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 50% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.

 

Goal


The goal of this activity is to improve learners’ competence in implementing optimal HIV treatment and prevention strategies through the appropriate use of contemporary ARV regimens.